midazolam has been researched along with Esophageal Squamous Cell Carcinoma in 3 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Esophageal Squamous Cell Carcinoma: A carcinoma that originates usually from cells on the surface of the middle and lower third of the ESOPHAGUS. Tumor cells exhibit typical squamous morphology and form large polypoid lesions. Mutations in RNF6, LZTS1, TGFBR2, DEC1, and WWOX1 genes are associated with this cancer.
Excerpt | Relevance | Reference |
---|---|---|
"Interruption of sedation due to a poor response to modified neuroleptanalgesia (m-NLA) with midazolam often occurs during endoscopic submucosal dissection (ESD) for esophageal squamous cell carcinoma (ESCC) because most patients have a history of heavy alcohol intake." | 9.27 | Comparison of propofol with midazolam in endoscopic submucosal dissection for esophageal squamous cell carcinoma: a randomized controlled trial. ( Arakawa, T; Fujiwara, Y; Fukunaga, S; Kamata, N; Kato, K; Machida, H; Maruyama, H; Minamino, H; Nagami, Y; Ominami, M; Sakai, T; Shiba, M; Sugimori, S; Tanaka, F; Tanigawa, T; Tominaga, K; Watanabe, T; Yamagami, H, 2018) |
"Interruption of sedation due to a poor response to modified neuroleptanalgesia (m-NLA) with midazolam often occurs during endoscopic submucosal dissection (ESD) for esophageal squamous cell carcinoma (ESCC) because most patients have a history of heavy alcohol intake." | 5.27 | Comparison of propofol with midazolam in endoscopic submucosal dissection for esophageal squamous cell carcinoma: a randomized controlled trial. ( Arakawa, T; Fujiwara, Y; Fukunaga, S; Kamata, N; Kato, K; Machida, H; Maruyama, H; Minamino, H; Nagami, Y; Ominami, M; Sakai, T; Shiba, M; Sugimori, S; Tanaka, F; Tanigawa, T; Tominaga, K; Watanabe, T; Yamagami, H, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ominami, M | 2 |
Nagami, Y | 2 |
Shiba, M | 2 |
Tominaga, K | 2 |
Sakai, T | 1 |
Maruyama, H | 2 |
Kato, K | 2 |
Minamino, H | 2 |
Fukunaga, S | 2 |
Tanaka, F | 1 |
Sugimori, S | 2 |
Kamata, N | 1 |
Machida, H | 1 |
Yamagami, H | 2 |
Tanigawa, T | 2 |
Watanabe, T | 2 |
Fujiwara, Y | 2 |
Arakawa, T | 2 |
Yoshio, T | 1 |
Ishiyama, A | 1 |
Tsuchida, T | 1 |
Yoshimizu, S | 1 |
Horiuchi, Y | 1 |
Omae, M | 1 |
Hirasawa, T | 1 |
Yamamoto, Y | 1 |
Sano, H | 1 |
Yokota, M | 1 |
Fujisaki, J | 1 |
Okamoto, J | 1 |
2 trials available for midazolam and Esophageal Squamous Cell Carcinoma
Article | Year |
---|---|
Comparison of propofol with midazolam in endoscopic submucosal dissection for esophageal squamous cell carcinoma: a randomized controlled trial.
Topics: Aged; Alcohol Drinking; Anesthetics, Intravenous; Endoscopic Mucosal Resection; Esophageal Neoplasms | 2018 |
Efficacy of novel sedation using the combination of dexmedetomidine and midazolam during endoscopic submucosal dissection for esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Anesthesia; Case-Control Studies; Dexmedetomidine; Drug Therapy, Combinatio | 2019 |
1 other study available for midazolam and Esophageal Squamous Cell Carcinoma
Article | Year |
---|---|
Prediction of Poor Response to Modified Neuroleptanalgesia with Midazolam for Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma.
Topics: Adjuvants, Anesthesia; Aged; Alcoholism; Carcinoma, Squamous Cell; Cross-Sectional Studies; Endoscop | 2016 |